Graves' Disease — A Visual Guide to Symptoms, Causes, Pregnancy & Treatment

What is Graves' disease?

Graves' disease is the most common cause of an overactive thyroid. It affects women several times more often than men¹ — but anyone can develop it — and it makes the whole body run too fast.

Next: how the thyroid feedback loop works →

How it works

The thyroid is run by a feedback loop between the brain and the gland. Switch modes to watch the healthy loop, see how Graves' jams it on, and how each treatment steps in. Hover any label for a plain-language definition.

Graves' by the numbers

Who gets Graves', when, and how often — the headline epidemiology.

Compare your labs to the dataset

Enter your thyroid panel and see where it lands against ~9,100 patients in the UCI reference dataset. Saved locally in your browser — nothing uploaded.

TRAK statistics

How well TRAK performs as a diagnostic, and how its level predicts relapse after antithyroid drugs.

Pregnancy statistics

Risks of untreated maternal Graves' and the postpartum relapse curve.

Real data — women only

Filtered to female records from the UCI thyroid dataset (n=1,830 women, 64 with hyperthyroid-spectrum diagnoses).

Reading the datasets

Column schema and copy-paste shell / Python recipes for the UCI Garavan thyroid files.

Files in ./datasets/ are comma-separated, no header row, with ? for missing values and the diagnosis appended as label.|recordID.

head -5 datasets/allhyper.data

awk -F',' '{print $NF}' datasets/allhyper.data \
  | awk -F'.' '{print $1}' | sort | uniq -c

awk -F',' '$2=="F" && $NF !~ /negative/' \
  datasets/allhyper.data

import pandas as pd
cols = ['age','sex','on_thyroxine','query_thyroxine',
        'on_antithyroid','sick','pregnant','surgery',
        'I131','q_hypo','q_hyper','lithium','goitre',
        'tumor','hypopit','psych',
        'TSH_m','TSH','T3_m','T3','TT4_m','TT4',
        'T4U_m','T4U','FTI_m','FTI','TBG_m','TBG',
        'referral','diagnosis']
df = pd.read_csv('datasets/allhyper.data',
                 names=cols, na_values='?')
df['diagnosis'] = df['diagnosis'].str.split('.').str[0]
df[df.sex=='F'].diagnosis.value_counts()

Causes — why me?

Graves' isn't caused by any single thing. It's a perfect storm: a genetic predisposition that primes the immune system, plus a trigger that tips it into producing the TRAK antibody. Most of the predisposition is unchangeable. Some of the triggers are.

The female life course

Graves' interacts with every major reproductive transition. The shape below is the relative incidence across a woman's life — a peak in the reproductive years, a second peak around menopause. Hover or tap any pin to see what changes at that stage.

Symptoms most people notice first

Graves' touches almost every system in the body. Symptoms below are ranked by how common they are in people with active disease¹ (approximate, from clinical literature — varies by sex, age, and severity).

How it's diagnosed

Diagnosis follows a defined sequence⁹: confirm hyperthyroidism with thyroid hormone labs, then confirm Graves' as the cause (rather than a toxic nodule or thyroiditis) with antibodies and/or imaging.

Differential diagnosis — Graves' vs other causes of hyperthyroidism

Course over time — what to expect

Graves' is a chronic condition with several possible long-term paths. The trajectory depends mostly on which treatment is chosen and how the immune system behaves after — relapse is common in the first 5 years, and a subset of people eventually drift into hypothyroidism even without RAI or surgery.

Common long-term patterns

Pregnancy & Graves'

For drug choices and trimester-by-trimester management, see the Treatment in pregnancy section below. This page focuses on what to watch for — fetal/neonatal effects, the thyroid-storm emergency, and the postpartum relapse window.

Risk timeline — what to watch for, when

Fetal & neonatal effects

Four possible problems — two driven by maternal TRAK crossing the placenta, two driven by maternal antithyroid drugs crossing the placenta.¹³

Thyroid storm in pregnancy

Postpartum — the relapse window

New hyperthyroid symptoms in the first 12 months postpartum are common¹² and split into two very different conditions — they look similar but the treatment and prognosis diverge sharply.

Just Diagnosed

Three disease-modifying options. None is best for everyone — the choice depends on age, pregnancy plans, severity, eye involvement, and your own preference.

Beta-blockers control symptoms but don't treat the disease.

Success rates at a glance

🩺 Doctor & follow-ups — at diagnosis

Questions to bring before you choose a treatment.

• What is my TRAK / TRAb level, and what does the magnitude mean for my prognosis?
• Are my TPO and thyroglobulin antibodies also positive? (overlap with Hashimoto's)
• What's my TSH, FT4, FT3 — and how far outside reference are they?
• Is there a goiter or nodule? Do I need a thyroid ultrasound or RAIU scan?
• Any signs of eye involvement? Should I see an ophthalmologist familiar with Graves' orbitopathy?
• Given my age & pregnancy plans, which treatment fits — ATD vs RAI vs surgery?
• Baseline DEXA (bone density), ECG, and vitamin D?
• What's my plan if I get pregnant on treatment?

On Medication

Your TRAK level is the single most useful number for predicting how the disease will behave and when you can stop antithyroid drugs.

TRAK (German TSH-Rezeptor-Antikörper; English TRAb / TSI) is the autoantibody that drives Graves' — it activates the TSH receptor on the thyroid and causes the disease.

What your band predicts

Approximate relapse risk after a standard 12–18 month antithyroid drug course, based on TRAK level at the end of treatment.⁸

🩺 Doctor & follow-ups — at each visit

What to ask while you're on treatment and watching your numbers.

• What are my latest TSH / FT4 / FT3 — and what's the trend vs last visit?
• Is my TRAK rising or falling? (especially before stopping ATD)
• Any change to drug dose? When's the next blood draw?
• If on ATD: when is my next CBC and LFT? Any new bruising, sore throat, or jaundice?
• How are my heart rate, weight, sleep, periods, mood?
• If post-RAI / surgery: am I on the right levothyroxine dose?
• Are we close to the point where I can try to stop ATD? What does my TRAK say?
• Any updates on guidelines or new options (e.g., teprotumumab for eye disease)?

Labs to track — the core thyroid panel

Treatment in pregnancy & breastfeeding

Pregnancy changes almost every treatment decision. Methimazole becomes risky in the first trimester; radioactive iodine is off the table entirely; some supplements need to be re-thought.

The full epidemiology, fetal/neonatal considerations, and postpartum relapse window are in the overview above — this section focuses on what to do.

Pre-conception planning

Ideally, achieve a stable euthyroid state before conception. Choices:

• On antithyroid drugs, controlled? Two accepted paths — decide with the endocrinologist before stopping contraception:
  • Pre-conception switch to PTU. Safest if conception may happen quickly — no window where an unrecognized early pregnancy (weeks 4–6) gets methimazole.
  • Stay on methimazole, switch at first positive test. Limits PTU liver exposure, but only works if she tests early and the switch happens within days — the teratogenic window (weeks 6–10) comes up fast.
• In remission, off drugs for ≥ 1 year? No PTU needed — but remission ≠ cure. TRAK antibodies can persist and cross the placenta regardless of maternal thyroid status. Required:
  • TRAK measured pre-conception and again at 18–22 weeks. If > 3× ULN, fetal monitoring (heart rate, growth, goiter on US) is indicated even if mom is euthyroid.
  • TSH / FT4 through pregnancy — relapse risk is elevated, especially postpartum (up to ~50% in the first year)¹².
• TRAK very high (>5× ULN) or large goiter? Consider definitive therapy (surgery preferred over RAI if planning pregnancy soon) 6+ months before trying — removes the drug question entirely.
• If RAI: wait at least 6 months and confirm euthyroid before trying.
• Already pregnant on methimazole? Switch to PTU urgently in 1st trimester (lower teratogenic risk).

Trimester-by-trimester management

Off the table during pregnancy

🩺 Doctor & follow-ups — pregnancy visits

Questions for each prenatal visit while managing Graves'.

• Am I on the right drug for this trimester (PTU in the first, switch to methimazole after)?
• What's the lowest ATD dose that keeps my FT4 in the upper-third target?
• What's my TRAK now — and do we need a fetal-monitoring plan if it's > 3× ULN?
• Are we tracking fetal heart rate & growth for signs of fetal thyroid trouble?
• What's the plan for labor (thyroid-storm precautions) and the postpartum relapse window?
• Will the baby need cord-blood / day-3 thyroid labs?

In Remission

Remission isn't a cure: relapse is common, especially in the first year and after pregnancy. Know the early signs — and the red flags that mean "call today."

Call your doctor the same day if

Natural remedies & lifestyle

Adjuncts only — these don't replace antithyroid drugs, RAI, or surgery. But three of them have strong enough evidence to matter.

Bottom line — the three highest-evidence moves

The full list — by category

Download all datasets

Eight sources, mixed access. Summary first; expand any row for the command-line recipe.

Dataset summary

Command-line recipes

# bash
mkdir -p datasets && cd datasets
BASE=https://archive.ics.uci.edu/ml/machine-learning-databases/thyroid-disease
for f in allhyper allbp sick-euthyroid hypothyroid sick allhypo; do
  curl -sSLO $BASE/$f.data
  curl -sSLO $BASE/$f.names 2>/dev/null
done
# index of all files
curl -s $BASE/ | grep -oE 'href="[^"]+"' | head -40

# 2007-2008 thyroid module (TSH, T4, antibodies)
mkdir -p datasets/nhanes && cd datasets/nhanes
curl -sSLO https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/THYROD_E.XPT
curl -sSLO https://wwwn.cdc.gov/Nchs/Nhanes/2007-2008/DEMO_E.XPT

# Python read
python3 -c "
import pyreadstat
df,_ = pyreadstat.read_xport('THYROD_E.XPT')
print(df.columns.tolist()[:15])
print(df.head())"

# 1. install CLI
pip install kaggle

# 2. get API token at https://www.kaggle.com/settings → Create API Token
#    saves kaggle.json — move it:
mkdir -p ~/.kaggle && mv ~/Downloads/kaggle.json ~/.kaggle/
chmod 600 ~/.kaggle/kaggle.json

# 3. download
cd datasets
kaggle datasets download -d emmanuelfwerr/thyroid-disease-data
kaggle datasets download -d yasserhessein/thyroid-disease-data-set
kaggle datasets download -d nguyenvy/nhanes-19882018
unzip -o "*.zip"

# Example: download a GEO series matrix
mkdir -p datasets/geo && cd datasets/geo
ACC=GSE9340
curl -sSLO "https://ftp.ncbi.nlm.nih.gov/geo/series/${ACC:0:5}nnn/$ACC/matrix/${ACC}_series_matrix.txt.gz"
gunzip -f ${ACC}_series_matrix.txt.gz

# Python alternative with GEOparse
pip install GEOparse
python3 -c "
import GEOparse
g = GEOparse.get_GEO('GSE9340', destdir='./')
print(g.metadata.get('summary'))"

# JSON API — no login
curl -sSL "https://clinicaltrials.gov/api/v2/studies?query.cond=Graves+Disease&pageSize=100" \
  -o datasets/clinicaltrials_graves.json
python3 -c "
import json
d = json.load(open('datasets/clinicaltrials_graves.json'))
print('Studies:', len(d['studies']))
for s in d['studies'][:5]:
    print('-', s['protocolSection']['identificationModule']['briefTitle'])"

Sources

Patient resources and further reading, followed by the full numbered reference list cited in the text — click any ² superscript on the page to jump straight to its entry.

Patient resources & further reading

References cited in the text

1. StatPearls — Graves Disease (NIH) — lifetime risk (~3% of women, ~0.5% of men) and the cardinal symptom list. ncbi.nlm.nih.gov
2. Change in newly diagnosed Graves' phenotype — meta-analysis, n=22,403 — goiter ~56%, eye-involvement ~25–34%. PMC
3. Krassas — menstrual disturbances in thyroid disease — irregular periods ~22% in modern series (50–60% in older ones). PubMed
4. Myopathies associated with thyroid disease — muscle weakness noticed by ~30%, detectable in ~80% on exam. MedLink
5. Alopecia & autoimmune thyroid disease — hair thinning reported in ~30–50%. touchENDOCRINOLOGY
6. Osteoporosis in hyperthyroid patients — BMD falls ~10–20%; osteoporosis up to ~45% in older/at-risk patients. PMC
7. High prevalence of infertility in Graves' & Hashimoto's — "difficulty conceiving" estimates span ~6–50% by population. PMC
8. Clinical Utility of TSH Receptor Antibodies (TRAK) — sensitivity & specificity both >95% (the ~97% / ~99% cited); TRAb level at end of course predicts relapse risk. PMC
9. 2016 ATA Guidelines for Hyperthyroidism (Ross et al.) — diagnostic sequence and differential diagnosis, plus treatment efficacy and complication rates (ATD remission ~40–50%, RAI >90%, surgery ~99%; hypoparathyroidism/nerve-injury risks). Thyroid (Liebert)
10. Thyroid Storm (StatPearls) — ~10–25% mortality even with treatment; far higher untreated. ncbi.nlm.nih.gov
11. Selenium and the course of mild Graves' orbitopathy (Marcocci et al., EUGOGO trial) — 200 µg/day for 6 months. NEJM
12. Graves' Disease and the Post-partum Period — relapse in roughly 1 in 3 within 12 months (up to ~50%). PMC
13. 2017 ATA Guidelines for Thyroid Disease in Pregnancy & Postpartum (Alexander et al.) — obstetric risks of uncontrolled hyperthyroidism (miscarriage, pre-eclampsia, preterm birth, low birth weight, stillbirth), PTU in the first trimester, and fetal/neonatal monitoring. Thyroid (Liebert)
14. Smoking is the strongest modifiable risk factor for Graves' orbitopathy (smokers ~5× the risk); cessation lowers its incidence, severity, and progression. Epidemiology & prevention of Graves' orbitopathy (PMC)
15. Excess iodine (kelp, supplements, iodinated contrast) can trigger or worsen Graves' — the Jod-Basedow effect; keep intake near the RDA (~150 µg/day) and avoid high-iodine supplements. Jod-Basedow syndrome (StatPearls)
16. L-carnitine reduced palpitations and tremor as an antithyroid-drug adjunct in a randomized trial. L-carnitine in hyperthyroidism — RCT (PubMed)
17. Celiac disease is several times more common with autoimmune thyroid disease (Graves' / Hashimoto's) — roughly 2–4× — so testing is worthwhile. Celiac & autoimmune thyroid disease (PMC)
18. Soy can modestly reduce levothyroxine absorption (~16–19% with larger amounts); separating doses by a few hours avoids it, and normal dietary amounts have little clinical impact. Soy & levothyroxine — narrative review (Endocrine Practice)

Symptom percentages are approximate and vary by study — not computed from this site's dataset. The cardinal symptoms (palpitations, heat intolerance, weight loss, anxiety, tremor; ref 1) are recognized as common (>50%), but exact figures differ between series.